November 2018 - Cancer Currents Blog
-
Genomic Test Helps Identify Thyroid Nodules That Don’t Require SurgeryThe test measures genomic changes in thyroid biopsy samples and generates a score based on how strongly each change is associated with thyroid cancer. A study showed the test accurately identified samples that, after surgery, were found to be benign.
-
Tailored Radiation to Treat Brain Metastases Reduces Impact on Cognitive FunctionResults from a clinical trial suggest that, in patients with brain metastases, an advanced radiotherapy technique limits harm to patients’ cognitive function without affecting the treatment’s effect on tumors.
-
Olaparib after Initial Treatment Delays Ovarian Cancer ProgressionIn a recent trial, the PARP inhibitor olaparib substantially delayed ovarian cancer from coming back after the first line of chemotherapy. Could the findings change the standard of care for newly diagnosed ovarian cancer with a BRCA mutation?
-
The Cancer Moonshot: Moving from Planning to ResearchDr. Dinah Singer, co-chair of the Cancer Moonshot Blue Ribbon Panel, provides an update to the cancer community on the science being supported under the Moonshot initiative.
-
NCI-MATCH Update: More Labs, New Arms, and Initial FindingsNCI’s Dr. Lyndsay Harris provides an update on the NCI-MATCH trial, including the opening of new trial treatment arms and the addition of new laboratories to perform testing on tumor samples of prospective trial participants.
-
Gene Tied to Alzheimer’s May Be Associated with Cancer-Related Cognitive ProblemsFindings from a clinical study and a mouse study may shed light on genetic risk factors for developing cancer-related cognitive problems in older breast cancer survivors. The results suggest a gene associated with Alzheimer’s disease may play a role.
-
Eight Factors May Link Disparities in Cancer Death Rates and IncomeEight factors may explain more than 80% of the relationship between poverty and disparities in cancer death rates at the county level, according to a new study. The largest mediator was a surprise to the researchers.
-
Blood Test Shows Promise for Detecting Genetic Changes in Brain TumorsA liquid biopsy blood test can detect DNA from brain tumors called diffuse midline gliomas, researchers have found. This minimally invasive test could be used to identify and follow molecular changes in children with these highly lethal brain tumors.
-
Reflections on My First Year as NCI DirectorOctober 2018 marked Dr. Norman Sharpless’s one-year anniversary as NCI director. He reflects on noteworthy events from the past 12 months and his excitement about leading NCI at such a critical juncture in the history of cancer research.